TMEM106B has also been reported to modulate patients’ cognitive functions in other neurodegenerative diseases, such as Alzheimer’s Disease (AD) [3], Parkinson’s Disease (PD) [4], and amyotrophic lateral sclerosis (ALS) [5]. This evidence concerns the gene TMEM106B and amyotrophic lateral sclerosis.